-
Loading metrics
Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial
- Neil Formica,
- Raburn Mallory,
- Gary Albert,
- Michelle Robinson,
- Joyce S. Plested,
- Iksung Cho,
- Andreana Robertson,
- Filip Dubovsky,
- Gregory M. Glenn,
- for the 2019nCoV-101 Study Group
x
- Published: October 1, 2021
- https://doi.org/10.1371/journal.pmed.1003769